Mark Graber, PhD, JD
Professor Mark A. Graber held a faculty position in the Department of Government and Politics at the University of Maryland, College Park, from 1993 to 2007 and taught at the University of Maryland School of Law as an adjunct professor beginning in the fall of 2002. In 2004, he was appointed Professor of Government and Law at Maryland Carey Law, a title he held until May 1, 2015, at which time he received an appointment as the Jacob A. France Professor of Constitutionalism.In 2016, he was named Regents Professor, one of only seven Regents Professors in the history of the University System of Maryland and the only Regents Professor on the UMB campus. He served as associate dean for research and faculty development from 2010 to 2013. He has also been one of the organizers of the annual Constitutional Law "Schmooze," which attracts scholars from across the country to the law school. Professor Graber is recognized as one of the leading scholars in the country on constitutional law and politics.He is the author of A New Introduction to American Constitutionalism (Oxford 2013), Dred Scott and the Problem of Constitutional Evil (Cambridge, 2006), and co-editor (with Keith Whittington and Howard Gillman) of American Constitutionalism: Structures and Powers and American Constitutionalism: Rights and Powers, both also from Oxford University Press, and co-editor with Mark Tushnet and Sandy Levinson of Constitutional Democracy in Crisis (Oxford 2018).His most recent book is Punish Treason, Reward Loyalty: The Forgotten Goals of Constitutional Reform After the Civil War (Kansas, 2023). Professor Graber is also the author of over 100 articles, including "The Non-Majoritarian Problem: Legislative Deference to the Judiciary" in Studies in American Political Development, "Naked Land Transfers and American Constitutional Development," published in the Vanderbilt Law Review and "Resolving Political Questions into Judicial Questions: Tocqueville’s Aphorism Revisited," published by Constitutional Commentary. He has been a visiting faculty member at Harvard University, Yale Law School, the University of Virginia School of Law, the University of Pennsylvania, the University of Toronto, the University of Oregon School of Law, and Simon Reichman University.For interview requests, please contact the Office of Communications and Public Affairs: https://www.umaryland.edu/news/for-the-mediaThis information was last updated February 19, 2024.
More from Youtube
- 0:50See Me Beyond My Disability #inspirationalvideoRecognize the humanity in people, and don't define them by their disabilities.Sydnee Chavis, DMD, MS, clinical assistant professor in the Department of Oral and Maxillofacial Surgery in the University of Maryland School of Dentistry, shares a story about growing up with her older sister, Brandy, who has cerebral palsy and developmental disabilities, and how she didn’t perceive her as different until the family was out to dinner one night.
- 0:55Why Don't People Trust Experts?Experts need integrity and benevolence above all else to gain public trust.Andrew Coop, PhD, MA, professor in the Department of Pharmaceutical Sciences and associate dean for Graduate Programs in the University of Maryland School of Pharmacy, shared those words during the third annual Faculty Convocation at the University of Maryland, Baltimore.Dr. Coop has been a faculty member at the University of Maryland School of Pharmacy since 1999, serving as chair of the Department of Pharmaceutical Sciences (PSC) from 2007 to 2015. In addition to his current role as UMSOP’s associate dean for graduate programs, he previously served as the school’s associate dean for academic affairs from 2016 to 2024 and as PSC’s vice chair of academic affairs from 2006 to 2007.Dr. Coop has received funding from the National Institutes of Health’s National Institute on Drug Abuse for his research on opioids, stimulants, and depressants, all of which were interdisciplinary projects concerned with the design and development of novel tools to allow pharmacological study of the biological systems involved in the abuse of these drugs.